In summary, ALKBH5 inhibits miR‐205‐5p expression by removing m6A modification to upregulate DDX5 expression, thereby promoting EMT and the AKI‐CKD transition after SA‐AKI. Here, ALKBH5 is linked to chronic kidney disease.